<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39326207</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Chronic lung inflammation and CK14+ basal cell proliferation induce persistent alveolar-bronchiolization in SARS-CoV-2-infected hamsters.</ArticleTitle><Pagination><StartPage>105363</StartPage><MedlinePgn>105363</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">105363</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2024.105363</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(24)00399-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-acute sequalae of COVID-19 defines a wide range of ongoing symptoms and conditions long after SARS-CoV-2 infection including respiratory diseases. The histopathological changes in the lung and underlying mechanism remain elusive.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We investigated lung histopathological and transcriptional changes in SARS-CoV-2-infected male hamsters at 7, 14, 42, 84 and 120dpi, and compared with A (H1N1)pdm09 infection.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">We demonstrated viral residue, inflammatory and fibrotic changes in lung after SARS-CoV-2 but not H1N1 infection. The most prominent histopathological lesion was multifocal alveolar-bronchiolization observed in every SARS-CoV-2 infected hamster (31/31), from 42dpi to 120dpi. Proliferating (Ki67+) CK14+ basal cells accumulated in alveoli adjacent to bronchioles at 7dpi, where they proliferated and differentiated into SCGB1A+&#xa0;club cell or Tubulin+&#xa0;ciliated cells forming alveolar-bronchiolization foci. Molecularly, Notch pathway significantly upregulated with intensive Notch3 and Hes1 protein expression in alveolar-bronchiolization foci at 42 and 120dpi, suggesting Notch signaling involving the persistence of alveolar-bronchiolization. This is further demonstrated by spatial transcriptomic analysis. Intriguingly, significant upregulation of some cell-growth promoting pathways and genes such as Tubb4b, Stxbp4, Grb14 and Mlf1 were spatially overlapping with bronchiolization lesion.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Incomplete resolution of SARS-CoV-2 infection in lung with viral residue, chronic inflammatory and fibrotic damage and alveolar-bronchiolization impaired respiratory function. Aberrant activation of CK14+ basal cells during tissue regeneration led to persistent alveolar-bronchiolization due to sustained Notch signaling. This study advances our understanding of respiratory PASC, sheds light on disease management and highlights the necessity for monitoring disease progression in people with respiratory PASC.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Funding is listed in the Acknowledgements section.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Can</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Wenchen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Alvin Hiu-Chung</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Feifei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Xinrui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>BGI Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Zhanhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yanxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Peidi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>BGI Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Jianpiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Andrew Chak-Yiu</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Zhihua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>BGI Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Jasper Fuk-Woo</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China; Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuen</LastName><ForeName>Kwok-Yung</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China; Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Hin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China; Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China. Electronic address: hinchu@hku.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Anna Jin-Xia</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, China. Electronic address: zhangajx@hku.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="Y">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011650" MajorTopicYN="N">Pulmonary Alveoli</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alveolar-bronchiolization</Keyword><Keyword MajorTopicYN="N">Basal cell</Keyword><Keyword MajorTopicYN="N">Hamster</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of interests We declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39326207</ArticleId><ArticleId IdType="pmc">PMC11470415</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2024.105363</ArticleId><ArticleId IdType="pii">S2352-3964(24)00399-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . WHO Coronavirus (COVID-19) dashboard. 2024. Accessed on May 09, 2024.</Citation></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart I., Jacob J., George P.M., et al. Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post-COVID-19 study. Am J Respir Crit Care Med. 2023;207(6):693&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037479</ArticleId><ArticleId IdType="pubmed">36457159</ArticleId></ArticleIdList></Reference><Reference><Citation>Adegunsoye A., Baccile R., Best T.J., et al. Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States. Lancet Reg Health Am. 2023;25:100566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10410516</ArticleId><ArticleId IdType="pubmed">37564420</ArticleId></ArticleIdList></Reference><Reference><Citation>Laura F., Samuel M., Fasihul A.K., et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. 2023;78(2):191.</Citation><ArticleIdList><ArticleId IdType="pubmed">35338102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B., Force R.M.P.T. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Heydemann L., Ciurkiewicz M., Beythien G., et al. Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2. Nat Commun. 2023;14(1):3267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10241385</ArticleId><ArticleId IdType="pubmed">37277327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wu H., Yu Y., Tang N. Pulmonary alveolar regeneration in adult COVID-19 patients. Cell Res. 2020;30(8):708&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338112</ArticleId><ArticleId IdType="pubmed">32632255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotton D.N., Morrisey E.E. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med. 2014;20(8):822&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229034</ArticleId><ArticleId IdType="pubmed">25100528</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajuyin A.M., Zhang X., Ji H.-L. Alveolar type 2 progenitor cells for lung injury repair. Cell Death Discov. 2019;5(1):63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6368612</ArticleId><ArticleId IdType="pubmed">30774991</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan A.E., Brumwell A.N., Xi Y., et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature. 2015;517(7536):621&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4312207</ArticleId><ArticleId IdType="pubmed">25533958</ArticleId></ArticleIdList></Reference><Reference><Citation>Salahudeen A.A., Choi S.S., Rustagi A., et al. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature. 2020;588(7839):670&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8003326</ArticleId><ArticleId IdType="pubmed">33238290</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo-Saganta A., Law B.M., Tata P.R., et al. Injury induces direct lineage segregation of functionally distinct airway basal stem/progenitor cell subpopulations. Cell Stem Cell. 2015;16(2):184&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334442</ArticleId><ArticleId IdType="pubmed">25658372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Zhang X., Lin Y., Zeng Y. Roles of airway basal stem cells in lung homeostasis and regenerative medicine. Respir Res. 2022;23(1):122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9102684</ArticleId><ArticleId IdType="pubmed">35562719</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner T., Allnoch L., Beythien G., et al. SARS-CoV-2 infection dysregulates cilia and basal cell homeostasis in the respiratory epithelium of hamsters. Int J Mol Sci. 2022;23(9):5124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9102945</ArticleId><ArticleId IdType="pubmed">35563514</ArticleId></ArticleIdList></Reference><Reference><Citation>Carraro G., Mulay A., Yao C., et al. Single-cell reconstruction of human basal cell diversity in normal and idiopathic pulmonary fibrosis lungs. Am J Respir Crit Care Med. 2020;202(11):1540&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7706153</ArticleId><ArticleId IdType="pubmed">32692579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano E., Suzuki T., Hashimoto R., et al. Cell response analysis in SARS-CoV-2 infected bronchial organoids. Commun Biol. 2022;5(1):516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9151746</ArticleId><ArticleId IdType="pubmed">35637255</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Khatun M.S., Zhang Z., et al. COVID-19 and influenza infections mediate distinct pulmonary cellular and transcriptomic changes. Commun Biol. 2023;6(1):1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10719262</ArticleId><ArticleId IdType="pubmed">38092883</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynds R.E., Janes S.M. Airway basal cell heterogeneity and lung squamous cell carcinoma. Cancer Prev Res. 2017;10(9):491&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">28821543</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaykhiev R. Airway basal cells in chronic obstructive pulmonary disease: a continuum or a dead end? Am J Respir Cell Mol Biol. 2021;65(1):10&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320128</ArticleId><ArticleId IdType="pubmed">33848453</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F., Zhang A.J., Yuan S., et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020;71(9):2428&#x2013;2446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184405</ArticleId><ArticleId IdType="pubmed">32215622</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz-Fontela C., Dowling W.E., Funnell S.G.P., et al. Animal models for COVID-19. Nature. 2020;586(7830):509&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136862</ArticleId><ArticleId IdType="pubmed">32967005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sia S.F., Yan L.-M., Chin A.W.H., et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7394720</ArticleId><ArticleId IdType="pubmed">32408338</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A.J., Lee A.C., Chan J.F., et al. Coinfection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters. Clin Infect Dis. 2021;72(12):e978&#x2013;e992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717201</ArticleId><ArticleId IdType="pubmed">33216851</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B., Chan K.H., Zhang A.J., et al. D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice. Exp Biol Med. 2010;235(8):981&#x2013;988.</Citation><ArticleIdList><ArticleId IdType="pubmed">20660098</ArticleId></ArticleIdList></Reference><Reference><Citation>Charan J., Kantharia N.D. How to calculate sample size in animal studies? J&#xa0;Pharmacol Pharmacother. 2013;4(4):303&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3826013</ArticleId><ArticleId IdType="pubmed">24250214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon K.H., 3rd, Leist S.R., Okuda K., et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci Transl Med. 2022;14(664)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9273046</ArticleId><ArticleId IdType="pubmed">35857635</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;bner R.H., Gitter W., El Mokhtari N.E., et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008;44(4):507&#x2013;511. 14-511.</Citation><ArticleIdList><ArticleId IdType="pubmed">18476815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Paggi J.M., Park C., Bennett C., Salzberg S.L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A., Liao S., Cheng M., et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell. 2022;185(10):1777&#x2013;1792.e21.</Citation><ArticleIdList><ArticleId IdType="pubmed">35512705</ArticleId></ArticleIdList></Reference><Reference><Citation>La Manno G., Soldatov R., Zeisel A., et al. RNA velocity of single cells. Nature. 2018;560(7719):494&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6130801</ArticleId><ArticleId IdType="pubmed">30089906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y., Hao S., Andersen-Nissen E., et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573&#x2013;3587.e29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez I.E., Eickelberg O. The impact of TGF-&#x3b2; on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc. 2012;9(3):111&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">22802283</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeown S., Richter A.G., Kane O., McAuley D.F., Thickett D.R. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J. 2009;33(1):77.</Citation><ArticleIdList><ArticleId IdType="pubmed">18829682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., Ye Z.W., Liang R., et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 omicron in Syrian hamsters. Science. 2022;377(6604):428&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">35737809</ArticleId></ArticleIdList></Reference><Reference><Citation>Merveille A.C., Davis E.E., Becker-Heck A., et al. CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs. Nat Genet. 2011;43(1):72&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3509786</ArticleId><ArticleId IdType="pubmed">21131972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.C., Zhang A.J., Chan J.F., et al. Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden Syrian hamsters. Cell Rep Med. 2020;1(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508015</ArticleId><ArticleId IdType="pubmed">32984855</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B., Aleman S., et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nat Immunol. 2023;24(10):1616&#x2013;1627.</Citation><ArticleIdList><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Martin J.C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeqing F., Bo D., Rongshuai W., et al. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. medRxiv. 2020 doi: 10.1101/2020.03.27.20045427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.27.20045427</ArticleId></ArticleIdList></Reference><Reference><Citation>Huot N., Planchais C., Rosenbaum P., et al. SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-&#x3b3; and NK cells. Nat Immunol. 2023;24(12):2068&#x2013;2079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10681903</ArticleId><ArticleId IdType="pubmed">37919524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee J., Thudium S., Renner D.M., et al. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature. 2022;610(7931):381&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533993</ArticleId><ArticleId IdType="pubmed">36198800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazdyrev E., Rusina P., Panova M., Novikov F., Grishagin I., Nebolsin V. Lung fibrosis after COVID-19: treatment prospects. Pharmaceuticals. 2021;14(8):807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8398080</ArticleId><ArticleId IdType="pubmed">34451904</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med. 2022;14(664)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen F., Meade-White K., Clancy C., et al. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract. Cell Rep. 2022;38(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860630</ArticleId><ArticleId IdType="pubmed">35263638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray S., Chiba N., Yao C., et al. Rare SOX2(+) airway progenitor cells generate KRT5(+) cells that repopulate damaged alveolar parenchyma following influenza virus infection. Stem Cell Rep. 2016;7(5):817&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5106521</ArticleId><ArticleId IdType="pubmed">27773701</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Y., Li A., Borok Z., Li C., Minoo P. NOTCH1 is required for regeneration of Clara cells during repair of airway injury. Stem Cells. 2012;30(5):946&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4005608</ArticleId><ArticleId IdType="pubmed">22331706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori M., Mahoney J.E., Stupnikov M.R., et al. Notch3-Jagged signaling controls the pool of undifferentiated airway progenitors. Development. 2015;142(2):258&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302835</ArticleId><ArticleId IdType="pubmed">25564622</ArticleId></ArticleIdList></Reference><Reference><Citation>Eenjes E., Buscop-van Kempen M., Boerema-de Munck A., et al. SOX21 modulates SOX2-initiated differentiation of epithelial cells in the extrapulmonary airways. Elife. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8331192</ArticleId><ArticleId IdType="pubmed">34286693</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa B.A., Ahmed M., Singh D.K., et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol. 2021;4(1):290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7935909</ArticleId><ArticleId IdType="pubmed">33674719</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias W.J., Frank D.B., Zepp J.A., et al. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. Nature. 2018;555(7695):251&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020060</ArticleId><ArticleId IdType="pubmed">29489752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballester B., Milara J., Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets. Int J Mol Sci. 2019;20(3):593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6387034</ArticleId><ArticleId IdType="pubmed">30704051</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.-Y., Demelash A., Kim H., et al. Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer. Am J Pathol. 2009;175(2):592&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2716959</ArticleId><ArticleId IdType="pubmed">19608871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou B., Zhou X.L., Lai S.Q., Liu J.C. Notch signaling and non-small cell lung cancer. Oncol Lett. 2018;15(3):3415&#x2013;3421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5796339</ArticleId><ArticleId IdType="pubmed">29467866</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Yang Y., Li X., Yuan X., Chu Q. Targeting the Notch signaling pathway and the Notch ligand, DLL3, in small cell lung cancer. Biomed Pharmacother. 2023;159</Citation><ArticleIdList><ArticleId IdType="pubmed">36645960</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraver A., Fern&#xe1;ndez-Marcos P.J., Herranz D., et al. Therapeutic effect of &#x3b3;-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell. 2012;22(2):222&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3813920</ArticleId><ArticleId IdType="pubmed">22897852</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia L.L., Johnson J.A., McErlean P., et al. SOX2 drives bronchial dysplasia in a novel organotypic model of early human squamous lung cancer. Am J Respir Crit Care Med. 2017;195(11):1494&#x2013;1508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5470746</ArticleId><ArticleId IdType="pubmed">28199128</ArticleId></ArticleIdList></Reference><Reference><Citation>Otaka Y., Rokudai S., Kaira K., et al. STXBP4 drives tumor growth and is associated with poor prognosis through PDGF receptor signaling in lung squamous cell carcinoma. Clin Cancer Res. 2017;23(13):3442&#x2013;3452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496791</ArticleId><ArticleId IdType="pubmed">28087642</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmapal D., Jyothy A., Mohan A., et al. &#x3b2;-Tubulin isotype, TUBB4B, regulates the maintenance of cancer stem cells. Front Oncol. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8733585</ArticleId><ArticleId IdType="pubmed">35004310</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A., Koul A.M., Wani U.M., et al. Dissection of paracrine/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis. BMC Cancer. 2023;23(1):926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10544320</ArticleId><ArticleId IdType="pubmed">37784035</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Yang Y., Wu K., Li Y., Shi M. Myeloid leukemia factor 1: a "double-edged sword" in health and disease. Front Oncol. 2023;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9939472</ArticleId><ArticleId IdType="pubmed">36814822</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Han S., Luo Y., et al. PERP may affect the prognosis of lung adenocarcinoma by inhibiting apoptosis. Cancer Manag Res. 2024;16:199&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10961073</ArticleId><ArticleId IdType="pubmed">38525370</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltos A., Khalil F., Smith M., et al. Clinical associations of mucin 1 in human lung cancer and precancerous lesions. Oncotarget. 2018;9(86):35666&#x2013;35675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6235019</ArticleId><ArticleId IdType="pubmed">30479696</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Liu Z., Zhong L., et al. High expression of growth factor receptor-bound protein 14 predicts clinical progression and poor prognosis in patients with lung adenocarcinoma. Res Square. 2020 doi: 10.21203/rs.3.rs-58001/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-58001/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F., Zhang Y., Wang S., et al. Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer. Sci Rep. 2014;4:3963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3912485</ArticleId><ArticleId IdType="pubmed">24492635</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Min S., Wang H., et al. MLF1 protein is a potential therapy target for lung adenocarcinoma. Int J Clin Exp Pathol. 2018;11(7):3533&#x2013;3541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962855</ArticleId><ArticleId IdType="pubmed">31949731</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Xiong X., Sun Y. Functional characterization of SOX2 as an anticancer target. Signal Transduct Targeted Ther. 2020;5(1):135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391717</ArticleId><ArticleId IdType="pubmed">32728033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>